Sophie Gobeil

Page Google Scholar

• Gobeil et al., Structural diversity of the SARS-CoV-2 Omicron spike. Molecular Cell. (2022) 82, 2050-2068. https://doi.org/10.1016/j.molcel.2022.03.028
• Gobeil et al., Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Science. (2021) 373, eabi6226 https://doi.org/10.1126/science.abi6226   
• Gobeil et al., D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction. Cell Reports. (2021) 34. https://doi.org/10.1016/j.celrep.2020.108630.
• Gobeil et al., Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics to Design Selective and Nonimmunosuppressive FK506 Analogs, mBio. (2021) e03000-21. https://doi.org/10.1128/mBio.03000-21
• Gobeil et al. The Structural Dynamics of Engineered β-Lactamases Vary Broadly on Three Timescales yet Sustain Native Function, Scientific Reports. (2019) 9. https://doi.org/10.1038/s41598-019-42866-8

Membre de l’Institut de biologie intégrative et des systèmes

• Stagiaire postdoctorale, Duke Human Vaccine Institute (2022)
• Stagiaire postdoctorale, biochimie, Duke University School of Medicine (2020)
• Ph.D., biochimie, Université de Montréal (2016)
• B.Sc., biochimie, Université de Montréal (2009)